Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating activities
Net income	$ 8,799	$ 7,983
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	1,383	1,404
Stock-based compensation expense	1,911	1,715
Deferred income taxes	(1,331)	137
Distribution of income from unconsolidated subsidiaries	852
Equity in income of unconsolidated subsidiaries	(1,255)
Gain (loss) on disposition of assets	59	(220)
Changes in assets and liabilities:
Cash held in escrow	2,828	(2,317)
Accounts receivable	(1,309)	2,183
Inventories	(21,254)	(51,637)
Prepaid expenses and other assets	47	347
Accounts payable	(7,429)	2,571
Accrued expenses and other liabilities	6,237	270
Net cash used in operating activities	(10,462)	(37,564)
Investing activities
Purchases of property and equipment	(1,052)	(2,784)
Proceeds from sale of assets		636
Proceeds from secured note receivable	25	24
Net cash used in investing activities	(1,027)	(2,124)
Financing activities
Borrowings under revolving credit facilities	45,000	50,000
Payments on revolving credit facilities	(175,000)	(25,000)
Proceeds from issuance of senior notes	127,500
Principal payments on notes payable	(1,582)	(515)
Debt issuance costs	(2,533)
Net proceeds from issuances of common stock	15,023
Repurchases of common stock upon vesting of restricted stock awards	(2,904)	(254)
Repurchases of common stock under our stock repurchase program		(2,393)
Net cash provided by financing activities	5,504	21,838
Net decrease in cash and cash equivalents	(5,985)	(17,850)
Cash and cash equivalents, Beginning of period	29,450	29,287
Cash and cash equivalents, End of period	$ 23,465	11,437
Supplemental cash flow disclosure
Cash paid for income taxes		$ 582